EcoDrugPlus

Retinoic Acid Receptor Alpha

Ensembl ID : ENSTNIG00000011157
Gene Symbol: RARA
2 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSTNIG00000018173
Gene Symbol: RARB
3 Cross references
393 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSTNIG00000001994
Gene Symbol: RARG
2 Cross references
411 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSTNIG00000015051
Gene Symbol: RARG
2 Cross references
424 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSTNIG00000006350
Gene Symbol: RXRA
2 Cross references
225 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2a

Ensembl ID : ENSTNIG00000008912
Gene Symbol: ROCK2A
2 Cross references
225 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2b

Ensembl ID : ENSTNIG00000012308
Gene Symbol: ROCK2B
2 Cross references
225 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSTNIG00000002616
Gene Symbol: RPL11
2 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSTNIG00000003442
Gene Symbol: RPL12
2 Cross references
479 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSTNIG00000017285
Gene Symbol: RPL13A
2 Cross references
368 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSTNIG00000009252
Gene Symbol: RPL14
2 Cross references
309 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSTNIG00000009797
Gene Symbol: RPL15
2 Cross references
357 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).